RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Carl Zeiss Meditec Stock

Carl Zeiss Meditec Net Income 2024

Carl Zeiss Meditec Net Income

169.16 M EUR

Ticker

AFX.DE

ISIN

DE0005313704

WKN

531370

In 2024, Carl Zeiss Meditec's profit amounted to 169.16 M EUR, a -41.75% increase from the 290.4 M EUR profit recorded in the previous year.

The Carl Zeiss Meditec Net Income history

YEARNET INCOME (undefined EUR)
2028e411.14
2027e352.49
2026e275.63
2025e221.58
2024e169.16
2023290.4
2022293.91
2021236.28
2020122.39
2019159.76
2018126.46
2017134.45
201698.33
201562.3
201475
201393.5
201271.9
201166.9
201054.9
200950.5
200854
200747.8
200626.7
200517.1
200412.6

Carl Zeiss Meditec Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Carl Zeiss Meditec, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Carl Zeiss Meditec from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Carl Zeiss Meditec’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Carl Zeiss Meditec. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Carl Zeiss Meditec’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Carl Zeiss Meditec’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Carl Zeiss Meditec’s growth potential.

Carl Zeiss Meditec Revenue, EBIT and net profit per share

DateCarl Zeiss Meditec RevenueCarl Zeiss Meditec EBITCarl Zeiss Meditec Net Income
2028e2.95 B EUR578.75 M EUR411.14 M EUR
2027e2.7 B EUR499.65 M EUR352.49 M EUR
2026e2.49 B EUR402.28 M EUR275.63 M EUR
2025e2.31 B EUR327.48 M EUR221.58 M EUR
2024e2.09 B EUR235.67 M EUR169.16 M EUR
20232.09 B EUR348.12 M EUR290.4 M EUR
20221.9 B EUR396.88 M EUR293.91 M EUR
20211.65 B EUR371.17 M EUR236.28 M EUR
20201.34 B EUR177.55 M EUR122.39 M EUR
20191.46 B EUR264.66 M EUR159.76 M EUR
20181.28 B EUR197.13 M EUR126.46 M EUR
20171.19 B EUR173.35 M EUR134.45 M EUR
20161.09 B EUR154.33 M EUR98.33 M EUR
20151.04 B EUR130.59 M EUR62.3 M EUR
2014909.3 M EUR120.7 M EUR75 M EUR
2013906.4 M EUR133.9 M EUR93.5 M EUR
2012861.9 M EUR122.9 M EUR71.9 M EUR
2011758.8 M EUR103.6 M EUR66.9 M EUR
2010676.7 M EUR86.5 M EUR54.9 M EUR
2009640.1 M EUR76.2 M EUR50.5 M EUR
2008600.2 M EUR68.2 M EUR54 M EUR
2007569.7 M EUR70.4 M EUR47.8 M EUR
2006390.6 M EUR47.8 M EUR26.7 M EUR
2005323.7 M EUR36.3 M EUR17.1 M EUR
2004234.9 M EUR25.5 M EUR12.6 M EUR

Carl Zeiss Meditec stock margins

The Carl Zeiss Meditec margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Carl Zeiss Meditec. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Carl Zeiss Meditec.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Carl Zeiss Meditec's sales revenue. A higher gross margin percentage indicates that the Carl Zeiss Meditec retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Carl Zeiss Meditec's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Carl Zeiss Meditec's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Carl Zeiss Meditec's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Carl Zeiss Meditec. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Carl Zeiss Meditec's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Carl Zeiss Meditec Margin History

Carl Zeiss Meditec Gross marginCarl Zeiss Meditec Profit marginCarl Zeiss Meditec EBIT marginCarl Zeiss Meditec Profit margin
2028e57.71 %19.61 %13.93 %
2027e57.71 %18.51 %13.06 %
2026e57.71 %16.16 %11.07 %
2025e57.71 %14.2 %9.61 %
2024e57.71 %11.27 %8.09 %
202357.71 %16.66 %13.9 %
202259.26 %20.86 %15.45 %
202158.73 %22.54 %14.35 %
202055.83 %13.3 %9.16 %
201957 %18.14 %10.95 %
201855.46 %15.39 %9.87 %
201755.19 %14.57 %11.3 %
201653.25 %14.18 %9.03 %
201551.89 %12.56 %5.99 %
201453.71 %13.27 %8.25 %
201353.82 %14.77 %10.32 %
201253.53 %14.26 %8.34 %
201154.67 %13.65 %8.82 %
201053.01 %12.78 %8.11 %
200950.35 %11.9 %7.89 %
200850.55 %11.36 %9 %
200751.87 %12.36 %8.39 %
200647.06 %12.24 %6.84 %
200547.08 %11.21 %5.28 %
200446.4 %10.86 %5.36 %

Carl Zeiss Meditec Aktienanalyse

What does Carl Zeiss Meditec do?

Carl Zeiss Meditec AG is a globally leading provider of medical technologies and devices for diagnostics and therapy. The company's history dates back to the founding of Carl Zeiss in 1846 in Jena, Germany. It has a long tradition in the development and manufacture of optical devices, particularly microscopes and binoculars. In 1996, Carl Zeiss decided to spin off its medical technology business segment and establish Carl Zeiss Meditec AG. Since then, the company has developed a wide portfolio of products used in ophthalmology and other medical fields. The business model of Carl Zeiss Meditec is based on three pillars: devices for diagnostics and therapy, software, and services. The devices are offered in various divisions specialized in specific application areas. The ophthalmology division is the largest and most well-known area of the company. It offers a wide range of diagnostic and therapy devices used in the treatment of eye diseases such as glaucoma, cataract, and retinal disorders. The products of the ophthalmology division include OCT systems (optical coherence tomography) for detailed examination of the retina, as well as VisuMax laser technology for correction of vision defects. Another important area of Carl Zeiss Meditec is the neurosurgery division. It offers devices for stereotactic neurosurgery used in the treatment of brain tumors, movement disorders, and other neurological conditions. The products of this division include the Kinevo stereotactic navigation system and the OPMI Neuro/NC4 surgical microscope series. In the dental division, Carl Zeiss Meditec provides innovative solutions for dentistry. This includes optical impression systems (Artemis), CAD/CAM systems, and dental microscopes. In addition to products, Carl Zeiss Meditec also offers software solutions for medical imaging and data processing. The FORUM software platform allows for intuitive management of medical images and findings. The company also provides training and education for doctors and medical professionals. The products of Carl Zeiss Meditec are known for their high quality, reliability, and precision. The company focuses on innovative technologies and continuously invests in research and development to strengthen its position as a market leader in the medical technology industry. Carl Zeiss Meditec is present in more than 60 countries worldwide and employs around 3,000 people. It is headquartered in Jena, Germany, and has additional locations in the United States, Canada, China, India, and other countries. Overall, Carl Zeiss Meditec AG is an innovative and reliable partner for the medical technology industry. Its wide range of products and services contributes to improving the health of millions of people worldwide. Carl Zeiss Meditec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Carl Zeiss Meditec's Profit Margins

The profit margins of Carl Zeiss Meditec represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Carl Zeiss Meditec's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Carl Zeiss Meditec's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Carl Zeiss Meditec's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Carl Zeiss Meditec’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Carl Zeiss Meditec stock

How much profit has Carl Zeiss Meditec made this year?

Carl Zeiss Meditec has made 169.16 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by -41.75% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Carl Zeiss Meditec publish its earnings?

Carl Zeiss Meditec publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Carl Zeiss Meditec?

The profits of Carl Zeiss Meditec are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Carl Zeiss Meditec?

You can learn more about the earnings of Carl Zeiss Meditec by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Carl Zeiss Meditec pay?

Over the past 12 months, Carl Zeiss Meditec paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 2.3 %. For the coming 12 months, Carl Zeiss Meditec is expected to pay a dividend of 1.22 EUR.

What is the dividend yield of Carl Zeiss Meditec?

The current dividend yield of Carl Zeiss Meditec is 2.3 %.

When does Carl Zeiss Meditec pay dividends?

Carl Zeiss Meditec pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Carl Zeiss Meditec?

Carl Zeiss Meditec paid dividends every year for the past 20 years.

What is the dividend of Carl Zeiss Meditec?

For the upcoming 12 months, dividends amounting to 1.22 EUR are expected. This corresponds to a dividend yield of 2.54 %.

In which sector is Carl Zeiss Meditec located?

Carl Zeiss Meditec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carl Zeiss Meditec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carl Zeiss Meditec from 3/26/2024 amounting to 1.1 EUR, you needed to have the stock in your portfolio before the ex-date on 3/22/2024.

When did Carl Zeiss Meditec pay the last dividend?

The last dividend was paid out on 3/26/2024.

What was the dividend of Carl Zeiss Meditec in the year 2023?

In the year 2023, Carl Zeiss Meditec distributed 0.9 EUR as dividends.

In which currency does Carl Zeiss Meditec pay out the dividend?

The dividends of Carl Zeiss Meditec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Carl Zeiss Meditec stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von Carl Zeiss Meditec

Our stock analysis for Carl Zeiss Meditec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carl Zeiss Meditec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.